home / stock / cala / cala news

CALA News and Press, Calithera Biosciences Inc. From 02/04/19

Stock Information
Company Name: Calithera Biosciences Inc.
Stock Symbol: CALA
Market: OTC
Website: calithera.com
Menu
CALA CALA Quote CALA Short CALA News CALA Articles CALA Message Board
Get CALA Alerts

News, Short Squeeze, Breakout and More Instantly...
CALA - Calithera Biosciences Completes Patient Enrollment in Randomized Phase 2 ENTRATA Trial of Telaglenastat (CB-839) and Everolimus in Renal Cell Carcinoma

SOUTH SAN FRANCISCO, Calif., Feb. 04, 2019 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment...
CALA - Analysis: Positioning to Benefit within Rollins, Hospitality Properties Trust, Exact Sciences, Tenet Healthcare, Entergy, and Calithera Biosciences - Research Highlights Growth, Revenue, and Consolidated Results

NEW YORK, Jan. 28, 2019 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Rollins, Inc. (NYSE:ROL), Hospitality Properties Trust (NASDAQ:HPT), Exac...

CALA - Calithera Biosciences Provides Corporate Updates and Announces Key Executive Promotions to Drive Continued Growth of the Company's Pipeline

SOUTH SAN FRANCISCO, Calif., Jan. 07, 2019 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical stage biotechnology company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment...

CALA - Calithera Biosciences, Inc. (CALA) CEO Susan Molineaux on Q3 2018 Results - Earnings Call Transcript

Calithera Biosciences, Inc. (CALA) Q3 2018 Earnings Conference Call November 07, 2018, 17:00 ET Executives Jennifer McNealey - VP, IR & Strategy Susan Molineaux - Co-Founder, CEO, President & Director Keith Orford - SVP, Clinical Development Stephanie Wong - SVP, Financ...
CALA - Calithera Biosciences reports Q3 results

Calithera Biosciences (NASDAQ: CALA ): Q3 GAAP EPS of -$0.52. More news on: Calithera Biosciences, Earnings news and commentary, Healthcare stocks news, , Read more ...

CALA - Calithera Biosciences Reports Third Quarter 2018 Financial Results and Recent Highlights

SOUTH SAN FRANCISCO, Calif., Nov. 07, 2018 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatmen...

CALA - Calithera Biosciences to Report Third Quarter 2018 Financial Results on Wednesday, November 7, 2018

SOUTH SAN FRANCISCO, Calif., Oct. 31, 2018 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage pharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatmen...
Previous 10 Next 10